Press Releases

01 Apr 2007

NeurOp Closes on $500K in Seed Financing
NeurOp Corporation, a preclinical stage pharmaceutical company focused on next generation drugs for CNS indications, announced today that it has closed on $500,000 in seed funding.

read more...

04 Feb 2007

NeurOp Garners Additional Federal Funds
NeurOp Corporation, a preclinical stage pharmaceutical company focused on next generation drugs for CNS indications, announced today that it has received a Phase 1 SBIR award from the National Institute of Neurological Disorders and Stroke (NINDS).

read more...

Home - Our Team - Technology - Markets and Indications - Funding Strategy - Press Releases - Contact Us